525 related articles for article (PubMed ID: 19832990)
1. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
Sellam J; Proulle V; Jüngel A; Ittah M; Miceli Richard C; Gottenberg JE; Toti F; Benessiano J; Gay S; Freyssinet JM; Mariette X
Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood.
Wang Y; Xie X; Zhang C; Su M; Gao S; Wang J; Lu C; Lin Q; Lin J; Matucci-Cerinic M; Furst DE; Zhang G
Ann Rheum Dis; 2022 Mar; 81(3):379-385. PubMed ID: 34462261
[TBL] [Abstract][Full Text] [Related]
3. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Novel Serum Proteomic Signature for Primary Sjögren's Syndrome.
Padern G; Duflos C; Ferreira R; Assou S; Guilpain P; Maria ATJ; Goulabchand R; Galea P; Jurtela M; Jorgensen C; Pers YM
Front Immunol; 2021; 12():631539. PubMed ID: 33708222
[TBL] [Abstract][Full Text] [Related]
5. Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren's syndrome or systemic lupus erythematosus.
Arcani R; Bertin D; Bardin N; Mazodier K; Jean R; Suchon P; Venton G; Daumas A; Jean E; Villani P; Kaplanski G; Jarrot PA
Rheumatology (Oxford); 2021 Sep; 60(9):4074-4084. PubMed ID: 33404653
[TBL] [Abstract][Full Text] [Related]
6. Altered β
Mobarrez F; Gunnarsson I; Svenungsson E
J Thromb Haemost; 2017 Sep; 15(9):1799-1806. PubMed ID: 28667788
[TBL] [Abstract][Full Text] [Related]
7. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren's syndrome and Graves' disease.
Al-Awadhi AM; Olusi S; Hasan EA; Abdullah A
Singapore Med J; 2007 Sep; 48(9):847-9. PubMed ID: 17728967
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
10. Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations.
Mobarrez F; Vikerfors A; Gustafsson JT; Gunnarsson I; Zickert A; Larsson A; Pisetsky DS; Wallén H; Svenungsson E
Sci Rep; 2016 Oct; 6():36025. PubMed ID: 27777414
[TBL] [Abstract][Full Text] [Related]
11. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D
Front Immunol; 2018; 9():322. PubMed ID: 29545790
[TBL] [Abstract][Full Text] [Related]
12. Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome highlight T cell-initiated autoimmunity.
Wang Y; Chen S; Chen J; Xie X; Gao S; Zhang C; Zhou S; Wang J; Mai R; Lin Q; Lin J; Matucci-Cerinic M; Zhang G; Furst DE
Ann Rheum Dis; 2020 Feb; 79(2):268-275. PubMed ID: 31848144
[TBL] [Abstract][Full Text] [Related]
13. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
14. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.
Zhao M; Zhou Y; Zhu B; Wan M; Jiang T; Tan Q; Liu Y; Jiang J; Luo S; Tan Y; Wu H; Renauer P; Del Mar Ayala Gutiérrez M; Castillo Palma MJ; Ortega Castro R; Fernández-Roldán C; Raya E; Faria R; Carvalho C; Alarcón-Riquelme ME; Xiang Z; Chen J; Li F; Ling G; Zhao H; Liao X; Lin Y; Sawalha AH; Lu Q
Ann Rheum Dis; 2016 Nov; 75(11):1998-2006. PubMed ID: 26787370
[TBL] [Abstract][Full Text] [Related]
15. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
17. Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suárez A
Int J Cardiol; 2017 Jun; 236():138-144. PubMed ID: 28279502
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
[TBL] [Abstract][Full Text] [Related]
19. Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
Zhou Z; Xu A; Teng J; Wang F; Tan Y; Liu H; Cheng X; Su Y; Shi H; Hu Q; Chi H; Li J; Hou J; Sun Y; Yang C; Ye J
J Immunol Res; 2020; 2020():2180708. PubMed ID: 33224991
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome.
Blokland SLM; van den Hoogen LL; Leijten EFA; Hartgring SAY; Fritsch R; Kruize AA; van Roon JAG; Radstake TRDJ
Rheumatology (Oxford); 2019 Oct; 58(10):1740-1745. PubMed ID: 31220315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
